Regulatory PathRegulatory requirements compared

Active substance

Mepivacaine

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
ISOCAINE 3 % CARTRIDGE3 %Solution for injection · Dental use50 CartridgeSAR 70.70Generic · PrescriptionNOVOCOLValid
MEDICAINE 3% CARTRIDGE30 mgSolution for injection in cartridge · Dental use50 CartridgeSAR 94.60NCE · PrescriptionLES LABORATOIRES MEDISValid
SCANDICAINE 3% CARTRIDGE 1.8ML3 %Solution · Dental use50 CartridgeSAR 99.60NCE · PrescriptionSEPTODENTValid
MEPECAINE 3% CARPULE3 %Solution for injection in cartridge · Dental use50 CartridgeSAR 50.40Generic · PrescriptionALEXANDRIA CO.Withdrawn by regulatory authority · Not Marketed
MEPICATON 3% CARTRIDGES (1.8)ML3 %Solution · Dental use50 CartridgeSAR 68.90Generic · PrescriptionWEIMER PHARMAWithdrawn by regulatory authority · Not Marketed
Indications — CHI Daman Drug Formulary

ANESTHESIA

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
SCANDONEST PLAIN3%injectable · injectionDEPROCOPrescription10 Oct 1984
POLOCAINE-MPF1%injectable · injectionFRESENIUS KABI USAPrescription1 Dec 1986
POLOCAINE1%injectable · injectionFRESENIUS KABI USAPrescription1 Dec 1986
POLOCAINE-MPF1.5%injectable · injectionFRESENIUS KABI USAPrescription1 Dec 1986
POLOCAINE-MPF2%injectable · injectionFRESENIUS KABI USAPrescription1 Dec 1986
POLOCAINE2%injectable · injectionFRESENIUS KABI USAPrescription1 Dec 1986
CARBOCAINE3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**injectable · injectionEASTMAN KODAKDiscontinued6 Jan 1960
CARBOCAINE1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**injectable · injectionHOSPIRADiscontinued17 May 1960
ISOCAINE HYDROCHLORIDE3%injectable · injectionSEPTODONTDiscontinued17 Oct 1972
MEPIVACAINE HYDROCHLORIDE3%injectable · injectionBELMORA LLCDiscontinued4 Dec 1973
ARESTOCAINE HYDROCHLORIDE3%injectable · injectionSOLVAYDiscontinued17 Dec 1975
MEPIVACAINE HYDROCHLORIDE1%injectable · injectionINTL MEDICATION SYSDiscontinued5 Oct 1982
POLOCAINE3%injectable · injectionDENTSPLY PHARMDiscontinued21 Aug 1984
MEPIVACAINE HYDROCHLORIDE1%injectable · injectionWATSON LABSDiscontinued20 Nov 1984
MEPIVACAINE HYDROCHLORIDE2%injectable · injectionWATSON LABSDiscontinued20 Nov 1984
MEPIVACAINE HYDROCHLORIDE3%injectable · injectionHOSPIRA INCDiscontinued28 Apr 2008

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
3% POLOCAINE DENTAL0233073330 MG / MLLIQUID · BLOCK/INFILTRATIONDENTSPLY CANADA LIMITED
CARBOCAINE 1%0224199910 MG / MLSOLUTION · INTRACAUDAL; EPIDURALPFIZER CANADA ULC
CARBOCAINE 1%0224200010 MG / MLSOLUTION · BLOCK/INFILTRATIONPFIZER CANADA ULC
CARBOCAINE 2%0224200120 MG / MLSOLUTION · EPIDURAL; INTRACAUDALPFIZER CANADA ULC
CARBOCAINE 3%0247417430 MG / MLSOLUTION · BLOCK/INFILTRATIONSEPTODONT
ISOCAINE HCL INJ 3%0036430430 MG / MLSOLUTION · BLOCK/INFILTRATIONNOVOCOL PHARMACEUTICAL OF CANADA INC
SCANDONEST 3% PLAIN INJ0047993430 MG / MLSOLUTION · BLOCK/INFILTRATIONSEPTODONT

Safety signals and safety-related labeling changes

  • US FDA 21 Dec 2023 CARBOCAINE — safety-related labeling change
    Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide

All safety entries for mepivacaine →

Combinations containing Mepivacaine

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.